Lipoprotein(a) and Risk of Ischemic Stroke in the REGARDS Study
- PMID: 30786745
- PMCID: PMC6511401
- DOI: 10.1161/ATVBAHA.118.311857
Lipoprotein(a) and Risk of Ischemic Stroke in the REGARDS Study
Abstract
Objective- Increased Lp(a) [lipoprotein(a)] is associated with coronary heart disease risk, but links with stroke are less consistent. Blacks have higher Lp(a) levels and stroke incidence than whites but have been underrepresented in studies. We hypothesized that Lp(a) is a risk factor for ischemic stroke and that risk differs by race. Approach and Results- REGARDS (Reasons for Geographic and Racial Differences in Stroke) recruited 30 239 black and white US adults aged ≥45 in 2003-2007 to study regional and racial differences in stroke mortality. We measured baseline Lp(a) by immunonephelometric assay in 572 cases of incident ischemic stroke and a 967-person cohort random sample. The hazard ratio of stroke by baseline Lp(a) was calculated using Cox proportional hazards models, stratified by race. Lp(a) was modeled in sex- and race-specific quartiles, given known differences in distributions by race and sex. Interactions were tested by including interaction terms in the proportional hazards models, with P<0.10 considered statistically significant. After adjustment for age, sex, and stroke risk factors, being in the fourth versus the first Lp(a) quartile was weakly associated with ischemic stroke overall, hazard ratio, 1.45 (95% CI, 0.96-2.19). In blacks, the hazard ratio was 1.96 (95% CI, 1.10-3.46), whereas in whites HR was 1.14 (95% CI, 0.64-2.04); P interaction=0.12. Lp(a) was lower in men than women, but associations with stroke in men and women were similar. Conclusions- We confirm that Lp(a) is a risk factor for ischemic stroke. Further research is needed to confirm the role of racial differences of the Lp(a) risk multiplier in ischemic stroke.
Keywords: incidence; lipoprotein(a); proportional hazards models; risk factors; stroke.
Conflict of interest statement
Disclosures and Conflicts of Interest
None
Similar articles
-
Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.Stroke. 2006 Jun;37(6):1407-12. doi: 10.1161/01.STR.0000222666.21482.b6. Epub 2006 May 4. Stroke. 2006. PMID: 16675734
-
Stroke incidence and mortality trends in US communities, 1987 to 2011.JAMA. 2014 Jul 16;312(3):259-68. doi: 10.1001/jama.2014.7692. JAMA. 2014. PMID: 25027141
-
Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study.J Thromb Haemost. 2017 Jun;15(6):1086-1094. doi: 10.1111/jth.13698. Epub 2017 May 9. J Thromb Haemost. 2017. PMID: 28393470 Free PMC article.
-
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.JAMA. 2009 Jul 22;302(4):412-23. doi: 10.1001/jama.2009.1063. JAMA. 2009. PMID: 19622820 Free PMC article. Review.
-
Reasons underlying racial differences in stroke incidence and mortality.Stroke. 2013 Jun;44(6 Suppl 1):S126-8. doi: 10.1161/STROKEAHA.111.000691. Stroke. 2013. PMID: 23709708 Free PMC article. Review. No abstract available.
Cited by
-
Addressing disparities in the global epidemiology of stroke.Nat Rev Neurol. 2024 Jan 16. doi: 10.1038/s41582-023-00921-z. Online ahead of print. Nat Rev Neurol. 2024. PMID: 38228908 Review.
-
Elevated atherogenic index of plasma associated with stroke risk in general Chinese.Endocrine. 2024 Jan 10. doi: 10.1007/s12020-023-03677-0. Online ahead of print. Endocrine. 2024. PMID: 38197990
-
Lipoprotein(a) and risk of cognitive impairment in Black and White Americans: the Reasons for Geographic and Racial Differences in Stroke cohort.Res Pract Thromb Haemost. 2023 Aug 8;7(6):102170. doi: 10.1016/j.rpth.2023.102170. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37694266 Free PMC article.
-
Thrombus composition and thrombolysis resistance in stroke.Res Pract Thromb Haemost. 2023 May 16;7(4):100178. doi: 10.1016/j.rpth.2023.100178. eCollection 2023 May. Res Pract Thromb Haemost. 2023. PMID: 37538503 Free PMC article.
-
Lipoprotein(a) and residual vascular risk in statin-treated patients with first acute ischemic stroke: A prospective cohort study.Front Neurol. 2022 Nov 3;13:1004264. doi: 10.3389/fneur.2022.1004264. eCollection 2022. Front Neurol. 2022. PMID: 36408516 Free PMC article.
References
-
- Dube JB, Boffa MB, Hegele RA and Koschinsky ML. Lipoprotein(a): more interesting than ever after 50 years. Curr Opin Lipidol. 2012;23:133–40. - PubMed
-
- Tsimikas S A Test in Context: Lipoprotein(a). Diagnosis, Prognosis, Controversies, and Emerging Therapies. J Am Coll Cardiol. 2017;69:692–711. - PubMed
-
- Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, Goldstein LB, Gorelick PB, Howard G, Kittner SJ, Manolio TA, Whisnant JP and Wolf PA. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke. 1997;28:1507–17. - PubMed
-
- Anderson TJ, Gregoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr., Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA and Ur E. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013;29:151–67. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
